Microbot Medical (NASDAQ:MBOT) Share Price Crosses Above Two Hundred Day Moving Average – Here’s What Happened

Microbot Medical Inc. (NASDAQ:MBOT) shares passed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $1.36 and traded as high as $2.11. Microbot Medical shares last traded at $1.65, with a volume of 33,273,909 shares traded.

Analyst Ratings Changes

Separately, HC Wainwright reaffirmed a “buy” rating and issued a $9.00 price target on shares of Microbot Medical in a research report on Thursday.

Microbot Medical Price Performance

The firm has a market cap of $77.48 million, a P/E ratio of -2.79 and a beta of 1.40. The company has a fifty day moving average of $1.67 and a 200-day moving average of $1.37.

Microbot Medical (NASDAQ:MBOT) last posted its quarterly earnings data on Wednesday, March 26th. The biotechnology company reported ($0.20) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.18) by ($0.02). On average, sell-side analysts expect that Microbot Medical Inc. will post -0.71 EPS for the current fiscal year.

Institutional Investors Weigh In On Microbot Medical

A hedge fund recently bought a new stake in Microbot Medical stock. Renaissance Technologies LLC bought a new stake in Microbot Medical Inc. (NASDAQ:MBOT) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 105,658 shares of the biotechnology company’s stock, valued at approximately $118,000. Renaissance Technologies LLC owned approximately 0.52% of Microbot Medical as of its most recent SEC filing. Institutional investors own 16.30% of the company’s stock.

Microbot Medical Company Profile

Microbot Medical Inc, a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces.